ReposiTrak (TRAK) Q1 2025 earnings summary

Executive summary

• Revenue increased 8% year-over-year to $5.44 million for fiscal Q1 2025, driven by recurring subscription and traceability services, with net income to common shareholders up 26% to $1.6 million.

• Traceability contributed 6% of total revenue, with onboarding accelerating due to major retailer mandates and the upcoming January 2026 FDA deadline.

• Operating income rose 23% to $1.5 million, and GAAP net income increased 21% to $1.7 million.

• The Board declared a quarterly cash dividend of $0.0165 per share, with a 10% increase approved for the next quarter.

• The company operates a SaaS platform for B2B e-commerce, compliance, traceability, and supply chain management, serving major food retailers and suppliers.

Financial highlights

• Recurring revenue comprised 98% of total revenue, slightly down from 99% due to higher non-recurring setup fees.

• Operating expenses increased 3% to $4 million, reflecting investments in automation, sales, and marketing.

• Basic EPS was $0.09, up from $0.07 in the prior year; diluted EPS was $0.08.

• Cash and cash equivalents increased to $25.8 million at quarter-end, with net cash from operations up 23% to $1.87 million.

• Gross margin remained strong, with cost of revenue at 16% of total revenue.

Outlook and guidance

• Management anticipates traceability revenue to increase sequentially through fiscal 2025, with a goal to double annual recurring revenue run rate over the next three years.

• Customers currently onboarding could increase revenue by 50% when fully integrated.

• The company expects to maintain 80% gross margins and continue growing EPS and operating cash flow.

• Existing cash and operating cash flow are sufficient to fund requirements for at least the next twelve months.